Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

45.53
+2.225.13%
Post-market: 45.20-0.3300-0.72%19:59 EST
Volume:1.89M
Turnover:84.11M
Market Cap:3.91B
PE:-10.49
High:45.79
Open:42.88
Low:42.48
Close:43.31
Loading ...

Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?

Insider Monkey
·
12 Dec 2024

Catherine Wood's Strategic Acquisition of CRISPR Therapeutics AG Shares

GuruFocus
·
11 Dec 2024

Analysts Are Bullish on Top Healthcare Stocks: Crispr Therapeutics AG (CRSP), Silence Therapeutics (SLN)

TIPRANKS
·
10 Dec 2024

Crispr Therapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
10 Dec 2024

CRISPR Therapeutics Says Trial Data Show CTX112 Has 'Potential' to Treat Malignancies

MT Newswires Live
·
10 Dec 2024

Crispr Therapeutics presents data on CTX112 at ASH Meeting

TIPRANKS
·
10 Dec 2024

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
10 Dec 2024

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
10 Dec 2024

2 Biotech Stocks to Buy Hand Over Fist in December

Motley Fool
·
07 Dec 2024

CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
07 Dec 2024

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

Zacks
·
06 Dec 2024

3 of the Best Growth Stocks You Can Buy for Less than $100

Motley Fool
·
05 Dec 2024

Caribou (CRBU) Develops Transformative Cell Therapies and Captures Investors’ Attention

TIPRANKS
·
04 Dec 2024

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
04 Dec 2024

Here's Why We're Not Too Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Situation

Simply Wall St.
·
04 Dec 2024

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Motley Fool
·
30 Nov 2024